Recent studies have reported that SOX3 is upregulated in cancer tissues and may therefore play an oncogenic role in esophageal squamous cell carcinoma, ovarian cancer, and T-cell lymphomas [22–24]. Here, SOX3 is linked to T-cell non-Hodgkin lymphoma.